The consequences of 'Brexit' for drug discovery and development, and the regulatory implications.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bernard T,Golding

第一单位： a Chemistry, School of Natural & Environmental Sciences and Northern Institute for Cancer Research, Bedson Building , Newcastle University , Newcastle upon Tyne , UK.

作者： Bernard T,Golding ^[1] ; Michael J,Waring ^[2]

作者单位： a Chemistry, School of Natural & Environmental Sciences and Northern Institute for Cancer Research, Bedson Building , Newcastle University , Newcastle upon Tyne , UK. ^[1] b Northern Institute for Cancer Research and Chemistry, School of Natural & Environmental Sciences, Bedson Building , Newcastle University , Newcastle upon Tyne , UK. ^[2]

关键词 Brexit EMA European medicines agency FDA Food & Drug Administration drug development drug discovery drug regulation

主题词动物(Animals);药物发现(Drug Discovery);制药工业(Drug Industry);欧盟(European Union);人类(Humans);立法, 药物(Legislation, Drug)

DOI 10.1080/17460441.2018.1463215

PMID 29634365

发布时间 2019-03-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交